# Scilex Holding Company (SCLX)

- Sector: Healthcare · Industry: Drug Manufacturers General
- SEC CIK: 0001820190 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001820190))
- Full page: https://inspectstocks.com/stocks/sclx
- Data as of: price 2026-09-28; newest filing used 2026-08-14; latest fiscal period ended 2026-06-30

## Grade

**C** on the growth-and-cash rubric, 3 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | failed | $31.6M | $46.5M |
| Revenue growing recently | passed | $31.6M | $30.3M |
| Free cash flow positive | passed | $3.7M |  |
| Free cash flow growing overall | passed | $3.7M | -$21.3M |
| Free cash flow growing recently | failed | $3.7M | $19.3M |

Business quality (the + / − mark): 3 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -1,469.8% |  |
| Healthy profit margin | failed | -1,469.8% |  |
| Strong operating margin | failed | -1,136.4% |  |
| Good return on equity | passed | 223.6% |  |
| Debt under control | passed | -0.47 |  |
| Turns sales into cash | passed | 11.7% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $31.6M |
| Net income, trailing twelve months | -$464.6M |
| Free cash flow, trailing twelve months | $3.7M |
| Net margin | -1,469.8% |
| Operating margin | -1,136.4% |
| Return on equity | 223.6% |
| Debt to equity | -0.47 |
| Diluted EPS, trailing twelve months | -$49.70 |
| Share price | $4.49 |
| Market value | $30.9K |
| Price / sales | 0.0x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/sclx)
- [Financial statements](https://inspectstocks.com/stocks/sclx/financials)
- [Competitors](https://inspectstocks.com/stocks/sclx/peers)
- [Earnings](https://inspectstocks.com/stocks/sclx/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.